Guggenheim Capital
AHCO icon

Guggenheim Capital’s AdaptHealth AHCO Stock Holding History

Guggenheim Capital’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Buy
20,294
+3,396
+20% +$37.9K ﹤0.01% 1633
2026
Q1 		$201K Sell
16,898
-48,047
-74% -$492K ﹤0.01% 1525
2025
Q4 		$647K Buy
64,945
+50,517
+350% +$482K ﹤0.01% 1156
2025
Q3 		$129K Buy
14,428
+443
+3% +$4.1K ﹤0.01% 1543
2025
Q2 		$132K Sell
13,985
-944
-6% -$8.33K ﹤0.01% 1543
2025
Q1 		$162K Sell
14,929
-1,684
-10% -$16.9K ﹤0.01% 1560
2024
Q4 		$158K Buy
16,613
+1,525
+10% +$15.4K ﹤0.01% 1622
2024
Q3 		$169K Buy
15,088
+935
+7% +$9.94K ﹤0.01% 1795
2024
Q2 		$142K Buy
14,153
+1,432
+11% +$14.6K ﹤0.01% 1798
2024
Q1 		$146K Sell
12,721
-2,891
-19% -$24.6K ﹤0.01% 1824
2023
Q4 		$114K Buy
+15,612
New +$123K ﹤0.01% 1846

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Reinhart Partners
Reinhart Partners Mequon, Wisconsin $4.11B AUM 38.38% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Guggenheim Capital's AHCO Position: Q2 2026 in Review

Guggenheim Capital increased its AdaptHealth (AHCO) stake by 20% in Q2 2026, buying an estimated $37.9K and bringing the position to 20,294 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #1633.

Guggenheim Capital first reported a position in AHCO in Q4 2023 and has held it in 11 quarters since. The position peaked at $647K in Q4 2025. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Guggenheim Capital held 20,294 shares of AdaptHealth worth $211K as of Q2 2026.
  • Guggenheim Capital bought 3,396 AdaptHealth shares in Q2 2026, an estimated $37.9K.
  • AdaptHealth made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1633 holding.
  • Guggenheim Capital first reported a position in AdaptHealth in Q4 2023 and has held it in 11 quarters since.
  • Guggenheim Capital's AdaptHealth position peaked at $647K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.